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Archaeal enzymes are playing an important role in industrial biotechnology. Many representatives of organisms living in “extreme”
conditions, the so-called Extremophiles, belong to the archaeal kingdom of life. This paper will review studies carried by the
Exeter group and others regarding archaeal enzymes that have important applications in commercial biocatalysis. Some of these
biocatalysts are already being used in large scale industrial processes for the production of optically pure drug intermediates and
amino acids and their analogues. Other enzymes have been characterised at laboratory scale regarding their substrate specificity
and properties for potential industrial application. The increasing availability of DNA sequences from new archaeal species and
metagenomes will provide a continuing resource to identify new enzymes of commercial interest using both bioinformatics and
screening approaches.
1. Introduction
The application of enzymes in “White Biotechnology” for
the synthesis of industrially important chiral compounds
is becoming increasingly important for the pharmaceutical
industry. Many companies who were traditionally not incor-
porating biocatalysis in their drug production programmes
are now very keen to develop the technology. Enzyme
chemistry can make reactions feasible which are currently
unavailable using conventional methods. Use of enzymes for
chemical processes is a route to lower energy consumption
and reduced waste generation. In addition, the selectivity of
enzymatic processes reduces the raw material costs and the
safety issues surrounding the production of wasteful biprod-
ucts. It is anticipated that optimised enzyme production
through further bioprocess intensification will lead to more
economically viable and cost effective, sustainable compound
production.
The wealth of genome and metagenome data now avail-
able makes searching for enzymes using both advanced
bioinformatic and substrate screening approaches an area
for development. Also more representatives of the different
classified enzyme groups are being investigated for their
application in industrial biocatalytic processes. The enzyme
process is often used in a “cascade reaction” with traditional
chemistry synthetic steps. When “nonnatural” industrial
substrates are presented to enzymes found in “nature” it has
been found that different classes of enzyme can use the same
nonnatural compound as a substrate to carry out a specific
biotransformation. This makes it difficult to predict which
class of enzyme should be best for the biocatalytic process.
Also using the enzyme in the presence of solvents or at
nonphysiological pH can result in “side reactions” which are
different from the normal activity of the enzyme catalyst.
The development of novel, efficient, and cost effective
biocatalytic processes in a variety of industries is currently
limited by the number of robust, highly selective, and useful
biocatalysts. This paper will concentrate on specific novel
enzymes from the archaeal kingdom that have been isolated
from thermophilic marine and terrestrial environments.
Thermophilic enzymes from archaea offer additional nov-
elty in relation to those from thermophilic bacteria since
they have been shown to be more primitive enzymes. An
example of this is the Sulfolobus solfataricus Glyceraldehyde
phosphate dehydrogenase (GAPDH) [1] which has the cat-
alytic cysteine on the same secondary structure as other
bacterial and eukaryotic ADHs but other residues involved
in catalysis are presented into the active site from different
secondary structural elements. This enzyme has only 18%
sequence identity to other well-characterised GAPDHs and
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was thought to have a different overall structure until the
crystal structure of the archaeal enzyme was determined.
Some archaeal enzymes have evolved by a different route
to their bacterial or eukaryotic equivalents in so much that
they are a combination of different enzymes such as the L-
aminoacylase from Thermococcus litoralis [2] that has only
L-aminoacylase activity but is related regarding its sequence
similarity to a carboxypeptidase enzyme from a Sulfolobus
species.
Many of the archaeal species have novel metabolic path-
ways that are not found in other kingdoms of life. For exam-
ple, some utilise modified versions of the canonical Emb-
den Meyerhof and Entner-Doudoroff pathway involving a
large number of novel enzymes [3] and have unusual pentose
degradation pathways.
Some archaeal enzymes are more promiscuous in their
activity than comparable enzymes from bacteria or eukar-
yotes: for example, the S. solfataricus, Picrophilus torridus
glucose/galactose dehydrogenase dehydratase, and gluco-
nate/galactonate dehydratase [4–6]. The archaeon S. solfatar-
icus has a promiscuity in 2-keto-3-deoxygluconate aldolase
from the Entner-Doudoroff pathway which is able to cleave
KDG and D-2-keto-3-deoxygalactonate (KDGal) to produce
pyruvate and D-glyceraldehyde. The aldolase also exhibits a
lack of stereoselectivity in the reversible condensation reac-
tion of pyruvate and D-glyceraldehyde. An understanding of
the structural basis of the promiscuity has been studied [7].
Enzymes isolated from thermophilic archaea usually are
more stable to high temperature, presence of solvents, and
resistance to proteolysis which together are ideal features for
industrial applications. Stability of an enzyme is dependent
on maintenance of a functional structure, and the stability
of any protein is marginal and equivalent to a small number
of molecular interactions [8]. This remains the case with
a thermostable protein, the only difference being that the
free energy of stabilisation is slightly higher than that of its
mesophilic counterpart [9]. The active form of a protein is
usually held together by a combination of noncovalent forces
including hydrogen bonds, ion pairs, hydrophobic bonds,
and Van der Waals interactions. When these interactions
are disrupted, for example, by elevated temperatures, both
mesophilic and thermophilic proteins unfold into inactive
but kinetically stable structures. Once unfolded in this man-
ner the protein is prone to aggregation and chemical modi-
fication. Aggregation occurs when the hydrophobic residues
of a protein that have been exposed by the polypeptide chain
unfolding interact with hydrophobic residues from other
protein molecules, which usually follows immediately after
unfolding. Chemical modifications of the protein can include
cysteine oxidation, deamination of asparagine and glutamine
residues, and peptide bond hydrolysis. The unfolding of the
protein may be reversible for smaller proteins but is usually
irreversible with larger proteins.
Although the optimal temperature for activity of the ther-
mostable archaeal enzymes is above what would normally be
used in an industrial process they can be used at lower tem-
peratures andusuallymaintain at least 20%of theirmaximum
activity at ambient temperature. There is often an advantage
to running a process at temperatures between 50 and 60∘C
since at this temperature many nonnatural substrates which
are insoluble at room temperature become soluble at the
higher temperature. The temperature for operation of the
industrial process needs to be balanced against the overall
economics of the biocatalytic conversion.
Many thermophilic enzymes can be cloned and overex-
pressed in a soluble form using amesophilic host (Escherichia
coli) and can be easily purified from the cell extract by a
straight forward heat treatment which precipitates most of
the mesophilic proteins. The features responsible for the
increased thermophilicity can be identified by studying the
biochemical and structural features of a range of purified
thermophilic proteins [10].These include an increase in ionic
interactions and often large ionic networks are observed
within the protein and at the subunit interfaces. This is
observed especially in hyperthermophilic proteins. The 𝛼-
helices in the protein can be “capped” so that an acidic
amino acid is placed to neutralise the charge of the protein
at the amino end of the helix and a basic amino acid to
neutralise the charge at the acidic end of the helix. Many
thermophilic proteins have increased hydrophobicity within
their interior and at subunit interfaces. This is especially
true for thermophilic proteins from Sulfolobus species. They
often have increased packing such as additional secondary
structures and C-terminal extensions which can pack into
the protein to fill unnecessary voids. Thermophilic proteins
usually have shorter surface loops and often the internal
loops can be stabilised by metal ions. An increased content
of proline residues is seen in some thermophilic bacteria
such as Thermus species which have a high G-C content in
their DNA. Generally there is a reduction in amino acids that
are unstable at high temperatures such as asparagines and
cysteines except where they play an important catalytic role.
Finally some species especially some of the aerobic archaea
such as Aeropyrum species use the introduction of a covalent
disulfide bond into the protein to offer the required stability
to high temperature.
This paper will address some important industrially
relevant biocatalytic reactions which can be carried out using
archaeal enzymes.
2. Biocatalytic Industrial Applications
2.1. Production of Carbocyclic Nucleotides. Carbocyclic nucle-
osides are valuable chemotherapeutic agents such as cardiac
vasodilators and are used in the treatment of viral infection.
New antiviral compounds are especially important for the
treatment of HIV since they act as nucleotide inhibitors of
the viral reverse transcriptase enzyme. The viral proteins
can readily mutate in order to overcome the inhibition.
New inhibitors therefore have to be continually developed.
An enzyme from the archaeon S. solfataricus MT4 can use
the bicyclic synthon (rac)-𝛾-lactam(2-azabicyclo[2.2.1]hept-
5-en-3-one) as a substrate to obtain a single enantiomer of
the 𝛾-bicyclic lactam product which is an important building
block for the anti-HIV compound, Abacavir (Scheme 1) [11].
This (+)-𝛾-lactamase was identified in the Sulfolobus strain
by screening colonies from an expression library for their
ability to produce the amino acid product when supplied
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Scheme 1: The lactamase catalytic process.
with the racemic 𝛾-lactam. Screening was carried out using
genomic libraries using a filter paper overlay. The colonies
on the plate that were active showed a brown colouration of
the filter paper when the amino acid was produced which
had been soaked in ninhydrin stain. Purified enantiomers of
the (+) or (−)-𝛾-lactam were used as substrates to determine
the stereospecificity of the enzyme.Another nonthermophilic
bacterial (+)-𝛾-lactamase that can also carry out this reaction
has been identified within the bacterium Delftia acidovorans.
This enzyme is of a different class, structure, and mechanism
from the archaeal enzyme but both can use the nonnatural
𝛾-lactam as a substrate. This archaeal 𝛾-lactamase has been
cloned and overexpressed in E. coli and purified to homo-
geneity. The molecular mass of the monomer was estimated
to be 55 kDa by SDS-PAGE which is consistent with the
calculated molecular mass of 55.7 kDa. The native molecular
mass was determined to be 110 kDa by gel filtration indicating
that the enzyme exists as a dimer in solution. The purified
enzyme has been crystallised with a view to determining its
three-dimensional structure.
The thermostable archaeal 𝛾-lactamase has a high
sequence homology to the signature amidase family of
enzymes. It shows similar inhibition patterns as the amidase
enzymes towards benzonitrile, phenylmethylsulfonyl fluo-
ride, and heavy metals such as mercury and it is activated
by thiol reagents. The enzyme selectively cleaves the (+)-
enantiomer from a 𝛾-racemicmixture. It also exhibits general
amidase activity by cleaving linear and branched aliphatic
and aromatic amides [12, 13].
Alignment of the amino acid sequences of the 𝛾-lactam-
ase from S. solfataricusMT4with 4 amidases fromPseudomo-
nas chlororaphis B23, Rhodococcus sp. N-771, R. erythropolis
N-774, and Rhodococcus rhodochrous J shows that it has a
41–44% sequence identity to these enzymes. The amidases
belong to the signature amidase family as they all contain the
consensus sequenceGGSS(S/G)GS.The amino acid sequence
of the 𝛾-lactamase contains the highly conserved putative
catalytic residues of aspartic acid and serine but not the highly
conserved cysteine residue [14].
The purified (+)-𝛾-lactamase enzyme has been immo-
bilised as a cross-linked, polymerised enzyme preparation
and packed into microreactors [15]. The thermophilic (+)-
𝛾-lactamase retained 100% of its initial activity at the assay
temperature, 80∘C, for 6 h and retained 52% activity after
10 h, indicating the advantage of the immobilisation.The high
stability of the immobilised enzyme provided the advantage
that it could be used to screenmany compounds in amicrore-
actor system without denaturation.
2.2. Transfer of Amine Groups. Many drugs are formed from
chiral amines and there has been increasing interest from
pharmaceutical companies to study the enzymes that can
transfer amine groups from one compound to another in a
stereospecific way. The transaminases catalyse the transfer of
an amino group from an amino acid to a ketoacid [16]. They
use the cofactor pyridoxal phosphate (PLP), the biologically
active form of vitamin B6. The PLP normally covalently
binds to an active site lysine amino acid by a Schiff base
(internal aldimine).Themechanismof transaminases ismade
up of two half-reactions. In the first half-reaction the donor
substrate gives its amino group to the cofactor, resulting
in a keto acid and enzyme-bound pyridoxamine-phosphate
(PMP). In the second half-reaction an amino group is
transferred from PMP to an acceptor keto acid, producing an
amino acid and restoring the PLP internal aldimine.
The archaeon S. solfataricus has been found to be an
interesting source of a thermostable transaminase enzyme
of group IV Pfam [17]. This pyridoxal phosphate containing
enzyme is involved in the nonphosphorylated pathway for
serine synthesis which is not found in bacteria and is found
in animals and plants. The transaminase reaction that the
enzyme carries out is the conversion of L-serine and pyruvate
to 3-hydroxypyruvate and alanine. Activity is also shown
towards methionine, asparagine, glutamine, phenylalanine,
histidine, and tryptophan. The enzyme can be used in
combination with transketolase for synthesis of chiral drug
intermediates [18].
The dimeric thermophilic archaeal transaminase enzyme
structure has been solved in the holo form of the enzyme
and in complex with an inhibitor gabaculine and in a
substrate complex with phenylpyruvate, the keto product of
phenylalanine [17]. Figure 1 shows a cartoon diagram of the
dimeric S. solfataricus transaminase with the cofactors PLP in
the two active sites.
The structural studies with this enzyme have given some
insight into the conformational changes around the active
site of the transaminase that occur during catalysis and have
helped to understand the enzyme’s substrate specificity. The
most related enzyme to the S. solfataricus transaminase is the
mesophilic yeast alanine:glyoxylate transaminase (AGAT)
which shares 37% amino acid identity [19]. The yeast AGAT
enzyme has been reported to have high substrate specificity
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Figure 1: A ribbon diagram of the structure of the Sulfolobus
transaminase dimer showing each monomer in a different colour
as viewed along the molecular twofold axis. The cofactor pyridoxal
phosphate (PLP) is shown bound to the active site lysine as a stick
model in the two active sites (PDB code 3ZRP). The figure was
constructed using CCP4mg [53].
for small amino acids such as alanine and glyoxylate, unlike
the Sulfolobus transaminase which exhibits a broad amino
acid substrate specificity. The substrate-binding pockets of
AGATs are remarkably similar to that of Sulfolobus enzyme.
The aromatic substrate phenylalanine was modelled into the
Sulfolobus enzyme active site and was compared with the
superimposed yeast AGAT enzyme structure. Most residues
in the vicinity of the modelled substrate are conserved
between the two proteins. The Sulfolobus enzyme has a
significantly larger substrate-binding pocket as its loop region
between strands 9 and 10 is two amino acids shorter. This
gives more space for the bulkier phenylalanine substrate
to bind compared with the AGAT enzyme, which is only
active towards alanine and glycine. An isoleucine residue in
AGAT occupies the space where larger substrates would sit
in the active site of the Sulfolobus enzyme. The isoleucine is
positioned 2.9 A˚ from the modelled substrate and hinders
the binding of any amino acid larger than alanine. In the S.
solfataricus transaminase enzyme there is a corresponding
valine residue in the position of the isoleucine of AGAT
which is positioned further away allowing the binding of
larger amino acids. These subtle differences between the
two enzymes are enough to change the enzymes substrate
specificity which is vitally important to understand for its use
in commercial applications.
The archaeal transaminase is relatively thermostable for
10 minutes at 70∘C and at pH 6.5. Features of the archaeal
enzyme that relate to its increased stability when compared
with the related AGAT enzyme show that the yeast enzyme
has 10 salt bridges compared to 21 salt bridges in the
Sulfolobus transaminase which includes several 3-4 amino
acid networks which offer increased stability. There is a C-
terminal extension in the Sulfolobus enzyme and shorter
surface loops which are all general features that are found
in thermophilic enzymes.The Sulfolobus transaminase dimer
interface is unusual being hydrophobic in nature with few
ionic interactions which are generally associated with more
thermophilic archaeal enzymes (Figure 2). This Sulfolobus
serine transaminase is the first example of a thermophilic
Figure 2: The structure of the Sulfolobus transaminase dimer
showing one subunit in surface space filling mode where the
white regions indicate hydrophobic regions and blue indicates basic
regions and red acidic regions. The other subunit is represented as a
𝛼-C chain showing that the subunit interface is mainly hydrophobic
(PDB code 3ZRP). The figure was constructed using CCP4mg [53].
Figure 3: A ribbon diagram of the structure of the Sulfolobus
dehalogenase dimerwith eachmonomer shown in a different colour.
The monomer has a core domain with a Rossmann-like fold of six-
stranded parallel 𝛽-strands surrounded by five 𝛼-helices and three
3
10
helices and a subdomain composed of 𝛼-helices. A substrate
mimic is shown in the two active sites as a stick model, located
between the two domains of each monomer (PDB code 2W11). The
figure was constructed using CCP4mg [53].
archaeal serine transaminase to be studied structurally and
to show that its properties meet the requirements for the
commercial application of the enzyme in biocatalysis.
2.3. Removal of Halogen Groups. Another archaeal enzyme
of industrial interest is found in Sulfolobus tokodaii. This L-
haloacid dehalogenase enzyme has been cloned and overex-
pressed in E. coli. It has been characterised biochemically and
structurally [20, 21].The enzymemonomer has two domains.
The core domain has a Rossmann fold with a six-stranded
parallel 𝛽-strand bundle surrounded by five 𝛼-helices and
three 3
10
helices. The subdomain is composed of 𝛼-helices.
The active site is located between the two domains and the
native enzyme forms a dimer as shown in Figure 3.
This enzyme has applications for chiral halo-carboxylic
acid production and bioremediation. Chiral halo-
carboxylic acids are important intermediates in the fine
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chemical/pharmaceutical industries. Removal of the halogen
group can be carried out by a dehalogenase. The Sulfolobus
enzyme has the potential to resolve racemic mixtures of
bromocarboxylic acids. This L-bromoacid dehalogenase is
able to catalyse the conversion of 2-halo-carboxylic acids to
the corresponding hydroxyalkanoic acids. It has been shown
to display activity towards longer chain substrates than the
bacterial Xanthomonas autotrophicus dehalogenase [22] with
activity seen towards 2-chlorobutyric acid. This is due to
a more accessible active site. The enzyme has a maximum
activity at 60∘C and a half-life of over an hour at 70∘C. It
is stabilised by a salt bridge and hydrophobic interactions
on the subunit interface, helix capping, a more compact
subdomain than related enzymes, and shortening of surface
loops. Another thermophilic enzyme of this family from
hyperthermophilic archaea has addressed the problem of
thermostability in a different way. The related Pyrococcus
dehalogenase (29% sequence identity) whose structure is
available from a structural genomics project is a monomeric
enzyme stabilised by a disulfide bond [23].
2.4. Hydrolysis and Esterification. Esterases are a class of
commonly used enzymes in industrial applications. This is
partially due to their inherent stability in organic solvents
and the ability to freely reverse the enzyme reaction from
hydrolysis to synthesis by the elimination of water that is used
in the hydrolysis mechanism. The carboxylesterases catalyse
the hydrolysis of the ester bond of relatively small water
soluble substrates. The carboxyl esterase NP originally iden-
tified from the fungus Ophiostoma novo-ulmi is used for the
production of the nonsteroidal pain killing drug, naproxen
[24]. The racemic naproxen methylester is hydrolysed to the
(S)-acid which is separated from the (R)-methylester to yield
(S)-naproxen with a 99% ee and a yield of 95%. It is important
that new drugs coming to market are of one optical form
preventing the problems associated with side effects of the
inactive enantiomer.
A thermostable carboxylesterase from the archaeon Sul-
folobus shibatae has been cloned, sequenced, and overex-
pressed in E. coli [25] (Toogood and Littlechild, unpublished
data). The enzyme has a 71 to 77% sequence identity to
an esterase from S. tokodaii and a carboxylesterase from
S. solfataricus strain P1, respectively [26, 27]. This enzyme
was identified as a serine esterase belonging to the mam-
malian hormone-sensitive lipase (HSL) family. It contains
the conserved putative catalytic triad residues Ser, Asp,
and His and is inhibited by the serine hydrolase inhibitors
phenylmethylsulfonyl fluoride andbenzamidine andpartially
inhibited by thiol reagents.The enzyme is thermostable, with
no loss of activity detected after 24 h at 60∘C.The enzymewas
able to cleave a variety of p-nitrophenyl ester substrates, with
the highest activity detected with p-nitrophenyl caproate.The
carboxylesterase was also tested for its ability to cleave a
variety of industrially relevant esters and diesters. It has a
preference for substrates containing aromatic groups such
as diethyl-2-benzyl malonate, benzyl acetoacetate, and Z-
phenylalanine methyl ester. However, it was also able to
enantioselectively cleave compounds such as 2-methyl-1,3-
propanediol diacetate.
2.5. Resolution of Amino Acids and Amino Acid Analogues.
Amino acids can be either of the “so-called” L configuration
as found in all proteins or of the D configuration found
in bacterial cell walls. The production of the specific L-
amino acids and amino acid analogues is important for
a variety of purposes. The industrial process to carry out
this biocatalytic reaction makes use of an L-aminoacylase
enzyme. A thermophilic archaeal version of this enzyme
has been cloned and overexpressed from the archaeon Ther-
mococcus litoralis [2]. The enzyme is a homotetramer of
43 kDa monomers and has an 82% sequence identity to an
aminoacylase from Pyrococcus furiosus and 45% sequence
identity to a carboxypeptidase from S. solfataricus. The
enzyme is thermostable, with a half-life of 25 hours at 70∘C.
Cell-free extracts of the aminoacylase were found to have
optimal activity at 85∘C in Tris-HCl pH 8.0. Conventional
aminoacylase inhibitors, such as mono-tert-butyl malonate,
have only a slight effect on its activity. The T. litoralis L-
aminoacylase has a broad substrate specificity preferring the
amino acids: Phe≫Met >Cys >Ala ≃Val >Tyr > Propargyl-
glycine > Trp > Pro > Arg. A column bioreactor containing
the recombinantThermococcus L-aminoacylase immobilised
onto Sepharose beads was constructed with the substrate, N-
acetyl-DL-Trp, continuously flowing at 60∘C for 10 days. No
loss of activity was detected over five days, with 32% activity
remaining after 40 days at 60∘C [28]. The enzyme has also
been immobilized into microreactors by covalent attachment
to expoxy resins in channels of the reactor which allow
the biocatalytic reaction to be carried out within this high
throughput “flow” system [29]. This can be used for rapid
screening of substrate specificity and eliminates problems
with product inhibition often seen in industrial reactions
which are carried out at high substrate concentrations. The
Thermococcus L-aminoacylase enzyme is now being used
in multiton commercial production of L-amino acids and
their analogues byChirotech/DowPharma andmore recently
by Chirotech/Dr. Reddy’s for large scale biotransformations
[30]. A racemase enzyme has been developed in order to
convert the isomer not used by the enzyme to the form
that is used which can enable a more efficient process with
potentially 100% conversion of a racemic substrate [31].
The hyperthermophilic L-aminoacylase from P. horiko-
shii has also been cloned and overexpressed in E. coli [32].
There are differences in substrate specificity between the
Thermococcus and the Pyrococcus enzymes. The substrate N-
acetyl-L-phenylalanine is the most favourable substrate for
theThermococcus enzyme; however, this substrate is not used
by the Pyrococcus L-aminoacylase.
2.6. Chiral Alcohol Production. A thermophilic aerobic ar-
chaeon Aeropyrum pernix is the source of a very stable
alcohol dehydrogenase (ADH) enzyme that can be used for
chiral alcohol production. This enzyme has been cloned
and overexpressed in E. coli [33]. The A. pernix ADH
enzyme is a tetrameric, zinc-containing, type I ADH with
a monomer size of 39.5 kDa. It has sequence identity to a
related horse liver ADH of 24% and the highest sequence
identity to a known structure is 39% to amedium chain ADH
from the hyperthermophilic archaeon S. solfataricus [34].
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Figure 4: A ribbon diagram of the structure of the Aeropyrum
alcohol dehydrogenase enzymemonomer showing the two different
domains: the Rossmann domain which binds the NADH cofactor
and the substrate-binding domain.The active site is located between
the twodomainswhere the cofactor and a substratemimic are bound
and shown as stick models. The two bound zinc ions are shown as
blue spheres: the catalytic zinc in the active site and the structural
zinc located in a distal loop. The active enzyme has a quaternary
structure of a tetramer of four identicalmonomers (PDB code1H2B).
The Figure was constructed using CCP4mg [53].
The A. pernix enzyme is highly specific for the cofactor
NAD(H) and displays activity towards a broad range of
alcohols, aldehydes, and ketones, while appearing to show
a preference for cyclic substrates. The enzyme is very ther-
mostable with a half-life of 2 hr at 90∘C. The maximal
activity is beyond 75∘C; however, there is still 10% activity
at 20∘C. The enzyme is solvent stable with over 50% activity
retained after incubation with 60% acetonitrile or dioxane.
The crystal structure of the enzyme has been determined
with an inhibitor bound into the active site [35]. The ADH
monomer is formed from a catalytic and a cofactor binding
domain, with the overall fold similar to previously solved
ADH structures (Figure 4). The 1.62 A˚ resolution A. pernix
ADH structure is that of the holo form, with the cofactor
NADH bound into the cleft between the two domains.
An inhibitor is bound in the active site which has been
interpreted to be octanoic acid. This inhibitor is positioned
with its carbonyl oxygen forming the fourth ligand of the
catalytic zinc ion (Figure 5). The enzyme is stabilised by an
ion-pair cluster at the subunit interfaces of the tetramer.There
are two zincs bound to the enzyme, one at the active site and
another at remote site which appears to stabilise the enzyme.
When the zinc does not occupy this second site a disulfide
bond is formed to hold the same two protein chains together
(Figure 6). It has now been predicted that disulfide bonds do
exist to stabilise many cytoplasmic proteins in this aerobic
archaeon, A. pernix [36].
The enzyme is active against primary and secondary alco-
hols with optimum chain length of C4-C5. It is most active to
large cyclic alcohols such as cycloheptanol and cyclooctanol.
The enzyme reaction can be reversed to produce chiral
alcohols by changing the pH. Initial experiments demonstrate
that the A. pernix ADH shows some stereoselectivity in the
reverse reaction producing the (S) phenylethanol [37] (Guy,
2002). The related Sulfolobus ADH has been reported to also
Figure 5: A ribbon diagram highlighting the details of the active
site of the Aeropyrum ADH enzyme showing the catalytic zinc ion
as a sphere together with the bound cofactor NADH and an enzyme
inhibitor in stick mode, defining the substrate-binding pocket (PDB
code 1H2B). The figure was constructed using CCP4mg [53].
be (S) selective showing enantiomeric excesses as high as 98%
[38] (Raia et al., 2001).
Other thermophilic archaeal alcohol dehydrogenases
have been characterised and are of the short chain or aldol
keto reductase family such as the short-chain Pyrococcus
furiosusADH [39] and the aldol keto reductaseThermococcus
kodakarensis ADH [40].
2.7. Cleavage of Lactone Rings. The specific cleavage of a
lactone ring is an important activity of interest to the
pharmaceutical companies. The lactonase enzymes identi-
fied to date fall into three structurally diverse groups: the
enol lactonases, gluconolactonases, and the quorum sensing
lactonases. Phosphotriesterase-like lactonases (PLLs) were
identified in the archaeal species S. solfataricus and S. aci-
docaldarius [41–44]. These enzymes catalyse the hydrolytic
cleavage of the intramolecular ester bond in lactones and
acyl-homoserine lactones (AHLs) to give the correspond-
ing hydroxyacylic acids. They also have a promiscuous
but significantly lower phosphotriesterase activity towards
organophosphate compounds. Recently an enzyme of this
class has been identified, cloned, overexpressed, and char-
acterised [45] from Vulcanisaeta moutnovskia a hyperther-
moacidophilic crenarchaeon that was recently isolated from
a solfataric field close to Moutnovsky volcano in Kamchatka
(Russia) [46]. The VmutPLL converted lactones and acyl-
homoserine lactones (AHLs) with comparable activities. A
promiscuous, significantly lower activity was observed to
organophosphates and only minor activity was observed
with carboxylesters. The catalytic activity strictly depended
on bivalent cations (Cd2+ > Ni2+ > Co2+ > Mn2+ >
Zn2+). The VmutPLL showed a pH optimum around 8.0, a
temperature optimum of 80∘C, and a half-life of 26min at
90∘C. The enzyme has demonstrated high activity towards
linear 𝛾-lactones with hydrophobic side chains of variable
lengths. These ranged from 𝛾-butyrolactone (no side chain)
and 𝛾-valerolactone which has a methyl side chain and
𝛾-dodecalactone which has a seven carbon side chain. It
was shown that the enzyme has activity to whiskey lactone
and 𝛿-dodecalactone. No measurable activity was seen for
mevalonolactone or 𝛿-decalactone. For two of the substrates
Archaea 7
Cys123
Cys115
Cys112
Zn
Asp109
(a)
Cys123
Cys115
Cys112
Asp109
(b)
Figure 6: (a)The binding site of the structural zinc ion in the Aeropyrum ADH enzyme. (b) When zinc is not present a disulfide bond forms
to stabilise the enzyme at this position in its structure (PDB code 1H2B). The figure was constructed with Bobscript [54].
𝛾-valerolactone and 𝛾-caprolactone, the optical isomeric
forms of these were tested to determine stereoselectivity of
the enzyme (Table 1). Results indicated that while activity is
seen with both isomers the enzyme seems to favour the D
form of these substrates.
The recent structure of the V. moutnovskia lactonase has
been carried out in complex with a long chain fatty acid
[47] which maps the substrate-binding pocket. This is lined
by hydrophobic side chains, which would provide affinity
for 𝛾-lactones of any side chain length. The homologous
lactonase from the S. islandicus is reported to favour 𝛾-lactone
substrates with long hydrophobic acyl chains of over four
carbons in length [48]. The substrate-binding site of the S.
islandicus lactonase revealed a number of polar residues at the
entrance of the substrate pocket with hydrophobic residues
lining the bottom of this pocket. This would disfavour the
binding of the smaller 𝛾-lactones in the correct catalytic
position.The different distribution of hydrophobic and other
residues in the active site pocket between the two related
enzymes appears to be responsible for their different catalytic
activities. The V. moutnovskia lactonase belongs to the ami-
dohydrolase superfamily with a (𝛽/𝛼)
8
-barrel structural fold.
In the V. moutnovskia enzyme these metals are two cobalt
ions [48] that are essential for activity and are located in at
the C-terminus of the 𝛽 barrel. The coordinating residues of
the metals are four histidines, one aspartate, and one lysine
which are highly conserved in this enzyme family. In the
proposed catalytic cycle the metal ions activate a bridging
water molecule through proton abstraction. The resulting
hydroxide ion then performs a nucleophilic attack on the C
1
of the lactone ring resulting in hydrolysis [49].
The high thermal stability of this enzyme as well as its
broad substrate specificity for different lactones AHLs and
OPs makes it an interesting new enzyme for commercial
biocatalysis. The enzyme is thought to have a natural role
in quorum sensing which plays a role in some of the
stages involved in biofilm formation [50, 51] and also in the
expression of virulence factors that are of interest in medic-
inal and biotechnological applications [52]. The enzymatic
degradation ofAHLs catalysed by the PLLs provides potential
for the interruption of quorum sensing signalling pathways
and the control of microbial communities.
3. Conclusions
This review has summarised some of the important industrial
applications using enzymes that have been identified from
a variety of different thermophilic archaea. It is expected
that the number of these enzymes used industrially will
increase due to their inherent stability and novel specificities.
The development of new rapid screening technologies and
improved bioinformatic approaches in combinationwith new
generation sequencing methodologies of archaeal genomes
and metagenomes will provide new enzymes for industrial
biotechnology.The enzymes can be cloned and overexpressed
in easily grown hosts such as E. coli allowing access to
sufficient quantities of the purified enzymes for detailed
biochemical and structural characterisation. The scale-up of
the enzyme production required for commercial applications
can be carried out by using a fungal host system which
allows export of the proteins into the growthmedium for easy
downstream processing. The cost of the enzyme biocatalyst
is often the most expensive component of the industrial
biotransformation and must be matched to the value of the
end product. Higher value optically pure compounds which
are important as drug intermediates for the pharmaceutical
industries will allow a high enzyme price. Other enzymes
that are required for the production of bulk chemicals, used
as additives for domestic cleaning products, used in food
production, or used to supplement biomass degradation pro-
cesses, generally need to be marketed at a cheaper price and
supplied in larger quantities.The stability of the biocatalyst is
also an important issue since the enzyme ideally needs to be
reused in several repeated biocatalytic cycles. Immobilisation
of the enzyme can often increase its stability and allow it
to be easily recovered for reuse. Thermostable enzymes are
usually more robust under industrial conditions and can be
used for repetitive biocatalytic conversions. The increased
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Table 1: The kinetic parameters of the activity of the VmutPLL enzyme with different lactone substrates. Taken from Kallnik et al., 2014 [45].
Substrate Structure Kcat [s−1] Km [mM] Kcat/Km [s−1∗M−1]
𝛾-(R)-valerolactone
O O
6.23 ± 0.42 4.56 ± 0.51 1327.1 ± 61.3
𝛾-(S)-valerolactone
O O
2.68 ± 0.00 1.95 ± 0.18 1379.95 ± 110.67
𝛾-(R)-caprolactone
O O
3.04 ± 0.01 0.55 ± 0.02 5563.72 ± 140.96
𝛾-(S)-caprolactone
O O
1.89 ± 0.11 0.75 ± 0.04 2531.22 ± 298.99
Whiskey lactone
OO
4.20 ± 0.06 0.93 ± 0.07 4538.63 ± 402.78
𝛾-Butyrolactone
O O
2.79 ± 0.07 11.57 ± 0.58 241.7 ± 11.18
pNP-acetate
N+
−O
O
O
O
1.66 ± 0.34 8.19 ± 1.10 201.74 ± 20.48
Methyl-paraoxon
N+
−O
O
O O
O
O
P 1.25 ± 0.40 2.79 ± 0.7 442.58 ± 50.14
use of enzymes from the extremophilic archaea offers the
opportunity to access biocatalysts that are naturally stable to
a variety of different conditions of temperature, pH, salinity,
and pressuremaking thembetter suited to different industrial
processes.
The use of enzymes in “White Biotechnology” is expected
to grow with biobased materials and chemicals produced
from emerging technologies predicted to rise globally to over
7.4 million metric tons in 2018 (Lux Research Analysts). The
initial process of enzyme discovery and optimisation is still
a limiting factor in the adoption of new biobased industrial
processes. There is therefore an increasing opportunity to
commercialise newly discovered archaeal enzymes for sus-
tainable manufacturing to contribute to the new circular
economy.
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